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Abstract
Background: Neuroinflammation in utero may contribute to brain injury resulting in life-long neurological
disabilities. The pivotal role of the efferent cholinergic anti-inflammatory pathway (CAP) in controlling inflammation,
e.g., by inhibiting the HMGB1 release, via the macrophages’ α7 nicotinic acetylcholine receptor (α7nAChR) has been
described in adults, but its importance in the fetus is unknown. Moreover, it is unknown whether CAP may also
exert anti-inflammatory effects on the brain via the anatomically predominant afferent component of the vagus
nerve.
Methods: We measured microglial activation in the ovine fetal brain near term 24 h after the umbilical cord
occlusions mimicking human labor versus controls (no occlusions) by quantifying HMGB1 nucleus-to-cytosol
translocation in the Iba1+ and α7nAChR+ microglia. Based on multiple clinical studies in adults and our own work
in fetal autonomic nervous system, we gauged the degree of CAP activity in vivo using heart rate variability
measure RMSSD that reflects fluctuations in vagus nerve activity.
Results: RMSSD correlated to corresponding plasma IL-1β levels at R = 0.57 (p = 0.02, n = 17) and to white matter
microglia cell counts at R = −0.89 (p = 0.03). The insult increased the HMGB1 translocation in α7nAChR+ microglia in
a brain region-dependent manner (p < 0.001). In parallel, RMSSD at 1 h post insult correlated with cytosolic HMGB1
of thalamic microglia (R = −0.94, p = 0.005), and RMSSD at pH nadir correlated with microglial α7nAChR in the white
matter (R = 0.83, p = 0.04). Overall, higher RMSSD values correlated with lower HMGB1 translocation and higher
α7nAChR intensity per area in a brain region-specific manner.
Conclusions: Afferent fetal CAP may translate increased vagal cholinergic signaling into suppression of cerebral
inflammation in response to near-term hypoxic acidemia as might occur during labor. Our findings suggest a new
control mechanism of fetal neuroinflammation via the vagus nerve, providing novel possibilities for its non-invasive
monitoring in utero and for targeted treatment.
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Background
Induced animal sepsis and clinical-pathologic studies in
adults indicate that loss of the cholinergic anti-
inflammatory pathway’s (CAP) inhibitory influence un-
leashes innate immunity, producing higher levels of pro-
inflammatory mediators that exacerbate tissue damage.
This decrease in CAP activity also decreases short-term
heart rate variability (HRV), e.g., as measured by the
beat-to-beat HRV measures, such as root mean square
of successive differences in R-R intervals of ECG
(RMSSD), a measure of vagal modulation of HRV [1, 2].
Thus, short-term HRV measures reflect CAP activity in
adults [3]. Of note, RMSSD also reflects vagal activity in
fetal sheep [4].
Increased CAP vagal activity inhibits the release of
pro-inflammatory cytokines such as interleukin (IL)-1β
[1]. This systemic CAP effect is mediated via the α7 nic-
otinic acetylcholine receptor (α7nAChR) expressed on
macrophages [5]. However, recent studies have shown a
similar α7nAChR-dependent effect in brain microglia in
vitro [6–8].
In adult species, high-mobility group box protein 1
(HMGB1), a non-histone DNA-binding protein, acts as
an important pro-inflammatory cytokine linking necrosis
with ensuing inflammation by translocating from the
neuronal nucleus to the cytosol and then to the extracel-
lular space, leading to microglial activation [9]. Much at-
tention has been paid to the effects of α7nAChR
stimulation on HMGB1 secretion because of its thera-
peutic potential to treat sepsis; HMGB1 represents a
crucial link between neuronal necrosis and the cerebral
inflammatory response mediated by microglia, thus
impacting the long-term outcome of neurological injury
[9, 10]. HMGB1 also acts as a potent pro-inflammatory
cytokine when secreted by microglia in response to in-
flammatory stimuli [11]. This requires translocation of
HMGB1 from nucleus to cytosol [9].
Systemic and neuroinflammation have been implicated
as important pathophysiological mechanisms acting in-
dependently to cause fetal brain injury or contributing
to hypoxic-asphyxial brain injury with consequences for
postnatal health [12, 13]. In the late-gestation ovine and
human fetus, the autonomic nervous system and cholin-
ergic vagal activity in particular are known to be suffi-
ciently mature [2, 14].
We have shown that CAP is active spontaneously near
term, such that individual baseline RMSSD values and
the levels of the pro-inflammatory cytokines IL-1β and
IL-6 are inversely correlated, reflecting spontaneous
CAP activity [15].
First, we hypothesized that the fetal inflammatory re-
sponse induced by hypoxic acidemia will result in an in-
crease of systemic CAP activity as a compensatory
mechanism and an inhibitory effect of CAP on the
cerebral inflammatory response. The systemic inflamma-
tory response will be reflected by an increased vagal ac-
tivity and hence a correlation of RMSSD and IL-1β.
Second, we sought to determine the effect of fetal
hypoxic-acidemia insult on brain regional activation
of the microglia expressing α7nAChR, and the rela-
tion of systemic and cerebral CAP activation to the
intracellular HMGB1 localization in these cells. Thus,
we hypothesized that the cerebral inflammatory re-
sponse will result in microglial HMGB1 translocation
from the nucleus to the cytosol due to increased
microglial activation via α7nAChR and this HMGB1
translocation will correlate with the degree of CAP’s
vagal activation measured by RMSSD.
Results
As reported, repetitive umbilical cord occlusions (UCO)
resulted in worsening acidosis over 3 to 4 h and eventu-
ally a severe degree of acidemia, fetal pH 7.36 ± 0.03 to
6.90 ± 0.13 (p < 0.01) [16].
RMSSD and IL-1β increased ~2-fold from baseline
versus the time of nadir pH (p < 0.05) and fell by
1 h of recovery (Fig. 1a, b; for IL-1β cf. [17]). Of
note, at 1 h of recovery, the values of RMSSD and
IL-1β were still clearly, but not statistically signifi-
cantly elevated. Baseline, nadir pH, and 1 h of recov-
ery RMSSD correlated to corresponding IL-1β levels
at R = 0.57 (p = 0.02, n = 17, Fig. 1c).
Fetal gender did not contribute to this correlation.
As reported, MG cell counts were increased in the
white matter of the treated animals versus the control
group [17]. RMSSD measurements at baseline and
1 h of recovery correlated inversely to white matter
MG cell counts determined at 24 h of recovery at
R = −0.71 (p = 0.05) and R = −0.89 (p = 0.03), respect-
ively (Fig. 1d).
We confirmed the specificity of the α7nAChR anti-
body for ovine brain tissue and the presence of the re-
ceptor in the ovine cerebellum and cortex (Fig. 2).
For both HMGB1 translocation index and α7nAChR
expression, the main effect of belonging to the UCO or
the control group was not significant (p = 0.25 and p =
0.54, respectively, Fig. 2). However, the effect of group
on HMGB1 translocation differed according to brain reg
(mostly in hippocampus and GM46) and microglia sta-
tus (p < 0.001 for interaction terms) (Additional file 1:
Table S2). Interestingly, statistically significant inter-
action effects on HMGB1 translocation were observed
in cortical and hippocampal regions, but not in the sub-
cortical (thalamus, white matter) brain regions. In gray
matter, these effects applied to quiescent MG (qMG),
but not to activated MG (aMG); meanwhile, in the
hippocampus, this was mostly apparent in aMG.
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Similarly, a model that accounted for interactions of
group and microglia status and HMGB1 was able to
predict α7nAChR expression (p < 0.001). Notably, the ef-
fect of UCO group was in the same direction but of
much greater magnitude in aMG compared to qMG
(Additional file 1: Table S3).
In parallel, RMSSD at 1 h of recovery correlated highly
with cytosolic HMGB1 intensity per area in aMG of
thalamus (R = −0.94, p = 0.005, Fig. 3a) and RMSSD at
pH nadir correlated with α7nAChR intensity per area in
aMG of WM (R = 0.83, p = 0.04, Fig. 3b). Similar to the
relationship shown in Fig. 3a, within both qMG and
aMG in WM, HMGB1 translocation index correlated to
RMSSD at 1 h of recovery (R = −0.83, p = 0.04 and R =
−0.89, p = 0.02, respectively). This finding was again rep-
licated for qMG of GM13 and aMG of GM46: HMGB1
translocation index correlated there to RMSSD at pH
nadir (R = −0.99, p < 0.001 and R = −0.83, p = 0.04, re-
spectively). That is, higher RMSSD values correlated
with lower HMGB1 translocation and higher α7nAChR
intensity per area in brain region-specific and microglia
status-specific manner.
To test whether UCO activate vagal brainstem nuclei,
we stained for c-Fos induction in the vagal dorsal motor
nucleus of UCO group compared to control animals.
This methodology had not yet been established in fetal
sheep model with the currently available c-Fos antibody.
Consequently, first, we confirmed the specificity of this
antibody for ovine brain tissue and the presence of the
receptor in the fetal near-term ovine brainstem, cerebel-
lum, and cortex (Additional file 2: Figure S1A and B).
Both 62 kDa and 55 kDa c-Fos proteins were detected as
expected. However, we were unable to establish reliable
staining of this activation marker in our paraffin-
embedded tissues (Additional file 2: Figure S1C). There-
fore, our findings regarding possible vagal brainstem
activation (or the absence thereof ) are inconclusive at
this stage of investigation.
Discussion
We demonstrate that UCO-induced insult simulating hu-
man labor results in increasing fHRV properties known to
reflect fluctuations of vagal activity. These fHRV properties
are correlated with systemic and brain inflammatory re-
sponses and with shifts in nucleus-cytosol HMGB1 distri-
bution in α7AChRs-positive microglia. We propose that
this behavior is due to an increase in afferent CAP activity
exerting anti-neuroinflammatory effects via microglial
α7AChRs by limiting microglial activation. We observe that
such effects occur in a brain region-dependent manner.
Efferent effects of fetal CAP and its relation to HRV
Our findings support the first hypothesis that near-term
asphyxia with worsening acidemia leads to vagal activa-
tion correlated to the degree of systemic inflammatory
response, which suggests CAP activation [4, 16, 17]. The
Fig. 1 a, b Fetal inflammatory response to acute hypoxic acidemia. *p < 0.05 versus baseline. pH nadir, at pH <7.00; recovery 1 and 24 h after the pH
nadir. Median ± {5–95 %}. c IL-1β measured at baseline, pH nadir, and 1 h or recovery correlates to RMSSD (R = 0.57, p= 0.02, n= 17). Baseline values were
chosen for lactate >1.5 mmol/l. d White matter microglia cell counts at 24 h recovery correlate to RMSSD at 1 h of recovery (R = 0.89, p= 0.03, n= 6)
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inhibition of brain regional cellular innate immune re-
sponse was found in fetuses that were subject to acute
worsening acidemia, but not to chronic intermittent
hypoxia [17, 18]. Consequently, fetal acidemia, but not
intermittent chronic hypoxia alone, is required for an
aseptic induction of fetal inflammatory response and
activation of CAP. Of note, duration of UCO insults, but
not levels of lactate per se, correlated to IL-1β in the
near-term fetuses [17]. In parallel with positive correl-
ation of IL-1β and RMSSD, this suggests that
Fig. 2 a Presence of α7nAChR in near-term ovine brain was confirmed by Western blot. b Effect of UCO, microglia status and brain regions on
HMGB1 translocation: significant group*brain region*microglia status interaction (p < 0.001). See Additional file 1: Table S1 for details. c Effect
of UCO and microglia status on α7 nAChR immunofluorescence measured as intensity per area: significant group*microglia status*HMGB1
translocation interaction (p < 0.001). See Additional file 1: Table S2 for details. Note that, for α7 nAChR signal, between-brain region comparisons
were not possible, because gain settings were optimized for each brain region and kept constant between cell compartment and groups (but
not from region to region). HMGB1 signal is expressed as ratio of cytosolic to nuclear signal, i.e., the higher the ratio, the more HMGB1 translocation is
observed; this normalization permits between-brain region comparisons
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chemoreceptor-mediated vagal activation results in part
from the CAP-mediated sensing of the systemic inflam-
matory response that is more pronounced with longer
duration of the stimulus.
Afferent effects of fetal CAP on neuroinflammation via
α7nAChR carrying microglia
To our knowledge, this is the first report relating sys-
temic vagal activity in vivo and the cerebral inflamma-
tory response in α7nAChR-labeled microglia, thus
providing in situ and in vivo support for our second
hypothesis, namely that CAP not only acts via efferent
peripheral pathway to suppress systemic levels of inflam-
mation but also targets neuroinflammation in the brain.
This anti-inflammatory effect is probably achieved via
the afferent branch of vagus nerve carrying cholinergic
signaling to the brainstem where it is relayed to the
higher subcortical and cortical regions. This notion is
supported by several considerations. First, ~80 % of
vagus nerve fibers are afferent and may provide feedback
to the cerebral CAP system synchronizing its responses
with those of the systemic CAP activity to the endogen-
ous (e.g., acidemia as shown in the present study) or ex-
ogenous (e.g., bacteria or viruses) inflammatory stimuli
[19]. Subdiaphragmatic vagatomy in adult rats activates
microglia in the brainstem regions involved in vagus
nerve signaling [20]. Second, vagus nerve stimulation
(VNS) has been used to treat drug-refractory epilepsy
for decades, yet the mechanism of action for VNS has
remained elusive [21]. Anti-inflammatory effects of VNS
may play a part in resetting the brain’s epileptogenic po-
tential [21]. Third, recent nascent work on mapping the
neuroimmunological homunculus has provided further
evidence for the far-reaching connection between per-
ipheral inflammation and cerebral perception and re-
sponses that are likely to include the vagus nerve as one
Fig. 3 UCO group: HMGB1 and α7 nAChR immunofluorescence are shown, measured as intensities per area (I/A) in activated microglia (aMG) in
relation to RMSSD as marker of CAP activity. RMSSD at 1 h recovery negatively correlates with cytoplasmic HMGB1 in thalamus a R = −0.94,
p = 0.005. RMSSD at pH nadir positively correlates with α7 nAChR in the white matter b R = 0.83, p = 0.04
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of the main communication pathways both to and from
the brain [22, 23]. Fourth, unlike its other cholinergic
counterparts, the α7nAChR can be activated by a pri-
mary ligand other than acetylcholine, i.e., choline [24].
Hence, the α7nAChR can function in areas of the brain
devoid of cholinergic transmission per se, where the far
more ubiquitous choline may act as a substitute ligand.
This may further contribute to a widespread effect of
cholinergic signaling in the brain via the α7nAChR.
Furthermore, we demonstrate in situ α7nAChR ex-
pression in fetal sheep microglia and the modulation of
this receptor’s immunofluorescent signal from nucleus
and cytosol/membrane compartments by hypoxic acide-
mia and microglia status. We show that fetuses with
higher RMSSD during severe acidemia showed lower
MG activation in the WM. We further show that this
may be mediated via α7nAChR in the WM’s activated
MG. α7nAChR stimulation on adult and neonatal mur-
ine derived microglia in vitro reduces secretion of LPS-
induced pro-inflammatory cytokine TNF-α [25, 26]. The
CAP-mediated effect of afferent cholinergic activity on
microglial HMGB1 release is further supported by nega-
tive correlation between the microglial thalamic cyto-
solic HMGB1 and vagal activation after reaching most
severe acidosis. The α7nAChR expression is not static
within a given brain region but rather appears to be dy-
namically regulated by stimuli such as hypoxic-ischemic
injury which downregulates α7nAChR mRNA, unless
the receptor is agonistically stimulated [7]. We propose
that such stimulation may not only be exogenous,
pharmacologically driven, but also endogenous and oc-
curring via afferent CAP. Indeed, fetal cerebral inflam-
matory response and ensuing CAP activation resulted in
a pronounced microglial α7nAChR intensity per area in-
crease in the periventricular WM and reduced cytoplas-
mic HMGB1 intensity per area in the thalamus, which
suggests that CAP homeostatically modulates microglia
activity toward a neuroprotective phenotype via
α7nAChR, similar teleologically to what has been pro-
posed by Tracey et al. for systemic peripheral efferent ef-
fects of CAP [5].
We identified microglia status-dependent differences
in HMGB1 translocation between cortical and subcor-
tical brain regions. These differences seemed amplified
by the UCO insult. UCOs are known to induce a redis-
tribution of the regional cerebral blood flow (rCBF) to-
ward subcortical structures [27]. In the hippocampal
subregions, HMGB1 translocation was noted in the ac-
tive microglia, while in the cortical layers 1–6 this was
true for the quiescent microglia. This may be explained
by a reportedly stronger rCBF increase in the hippocam-
pus than in cortex under a similar UCO insult [27]. The
relative rCBF increase in the hippocampus may also in-
crease its exposure to the systemically circulating pro-
inflammatory cytokines and lactic acid which upregu-
lates microglia [28, 29]. We observe this as a stronger
Iba1+ signal, larger microglial cell bodies and processes
with close proximity to the neurons (cf. Fig. 4). This
finding further contributes to the observation that the
hippocampus is one of the brain regions most suscep-
tible to hypoxic-ischemic insults [27]. Further studies
are needed to better characterize the fetal microglial
phenotypes involved in the UCO insult using morpho-
logical, morphometric, and more sophisticated bio-
marker approaches.
Is there evidence that UCO activate brainstem vagal
centers?
Labor contractions induce widespread c-Fos activation
in the hypothalamic and thalamic nuclei, hippocampus,
and cerebral cortex of pregnant rats that were subjected
to umbilical cord occlusions [30]. This and other studies
done in postnatal animals have in common that tissues
were collected within 1–2 h post insult and cryosections
were prepared for c-Fos immunohistochemistry [31–33].
Our study differs in both respects: we collected tissues
24 h post insult and used paraffin embedding, since at
the time the focus was on neuroinflammation and brain
injury; c-Fos studies were not part of the plan. As such,
albeit the herein reported c-Fos findings are not conclu-
sive, we chose to provide the complete methodology for
the scientific community to be able to continue our
work using this solely available commercial antibody. At
present, it remains possible that c-Fos activation due to
UCO subsided when measured at 24 h post pH nadir or
was not visible in the paraffin-embedded tissues and
cryosections should have been used. Regardless, our
conclusions on the potential role of CAP in the medi-
ation of neuroinflammation stand and are subject to val-
idation in future studies.
The analysis of positive controls in fetal brains that were
exposed to afferent vagus nerve stimulation, a unique ex-
perimental model of vagus nerve manipulation established
recently in our laboratory, showed yet again no clear
presence of c-Fos immunostaining (Additional file 2:
Figure S1C). Since the slides used for this validation were
also paraffin-embedded, a standard procedure for our
studies, we suggest that the likely conclusion to this aspect
of the study is that cryosections are key to preserving and
visualizing c-Fos, at least using this particular antibody.
In summary, we cannot, at present, draw any definitive
conclusion that at 24 h post UCO no c-Fos signal is seen
in the vagal dorsal motor nucleus. Cryosectioning is
needed to bring out the signal. Here, we present the im-
munohistochemical approach in fetal sheep brainstem
and confirm the validity of the antibody chosen using
Western Blot. We leave this aspect to further develop-
ment in future studies.
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Clinical implications
In a series of experiments in chronically instrumented
unanesthetized fetal sheep, an important model of hu-
man pregnancy, we showed that a fetal systemic and
cerebral inflammatory response required the presence of
severe hypoxic acidemia and was not induced by chronic
hypoxia alone as might occur in the late gestation hu-
man fetus during labor or antenatally with growth re-
striction, respectively [34]. Since RMSSD, as a measure
of vagal activity, increases in response to perinatal
acidemia and inflammation [4, 35], we sought to deter-
mine the extent to which measures of systemic and cere-
bral inflammation in the fetus relate to RMSSD and
indicate peripheral and cerebral CAP activity. We have
induced fetal inflammation with hypoxic acidemia [36].
This stimulus activates systemic and cerebral innate im-
mune responses and corresponds to a frequently ob-
served spectrum of fetal heart rate distress patterns
during human labor. Severe fetal acidemia (pH <7.00) at
birth is observed in ~0.5–10 % of human births [37, 38].
Fig. 4 α7nAChR + HMGB1 + Iba1 + DAPI immunofluorescent staining: Red = Iba1; Blue = DAPI; Green = HMGB1; White = α7nAChR. Images were
made from extended depth of focus, maximum intensity projections from convexial gray matter layers 4 to 6. Top: Features of active versus
inactive microglia: Inactive cells have no interaction with neurons, are smaller, less bright, and less ramified versus the activated cells. Bottom:
Co-localization staining for Iba1+ cells expressing α7nAChR with intracellular localization of HMGB1 and DAPI counterstain. a Iba1 + DAPI
+ α7nAChR; b Iba1 + DAPI + HMGB1; c Iba1+ α7nAChR; d best focus color composite of Iba1+ α7nAChR + HMGB1 + DAPI
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Approximately 20 % of these babies will have neurologic
sequelae including hypoxic-ischemic encephalopathy
(HIE) and cerebral palsy [39–41]. Every fifth baby with
cerebral palsy will have had an asphyxial event during
birth, and every 10th, some degree of inflammatory ex-
posure, with antenatal growth restriction and chronic
hypoxia identified as another major contributing factor
[42]. This is supported by animal research indicating
that chronic hypoxia, prior to an acute asphyxia event,
alters the interplay between the fetal neuroinflammatory
and neuronal responses to the insult, potentially exacer-
bating the long-term effects of the exposure [28]. Over-
all, antenatal hypoxia and perinatal hypoxic acidemia are
major contributors to perinatal brain injury resulting in
increased risk for acute or life-long morbidity and mor-
tality [43, 44]. Our findings suggest that an endogenous
neuroinflammatory control mechanism, CAP, plays a
neuroprotective role in etiology of early perinatal brain
injury and that this mechanism may be monitored non-
invasively using trans-abdominal fetal ECG technology.
The latter conjecture is supported by a series of recent
studies in fetal sheep and human labor cohorts [45–48].
Conclusions
Our study provides first evidence of a neuroimmunolo-
gical link in the late gestation fetus. Enhancing fetal
CAP activity may suppress activation of microglia, there-
fore promoting neuroprotection. This may improve
postnatal short- and long-term health outcomes through
decreasing lasting brain injury.
Methods
Ethics statement
This study was carried out in strict accordance with
the recommendations in the Guide for the Care and
Use of Laboratory Animals of the National Institutes
of Health. The protocol has been approved by the
Committee on the Ethics of Animal Experiments of
the University of Western Ontario (Permit Number
2006-091-08 “Intrapartum fetal monitoring: markers
of hypoxic related injury”).
Surgical preparation
Fetal sheep near term (0.86 gestation) of mixed breed were
surgically instrumented with umbilical cord occluders to
induce hypoxic acidemia (n = 10 + 5, further referred to as
UCO group compared to control group which was also in-
strumented but not subjected to UCOs). The anesthetic
and surgical procedures and postoperative care of the ani-
mals have been described [23]. Briefly, using sterile tech-
nique under general anesthesia (1 g thiopental sodium in
solution intravenously (IV) for induction; Abbott Labora-
tories Ltd., Montreal, Canada; followed by 1 to 1.5 % halo-
thane in O2 for maintenance), a midline incision was
made in the lower abdominal wall, and the uterus was pal-
pated to determine fetal number and position. The upper
body of the fetus and proximal portion of the umbilical
cord were exteriorized through an incision in the uterine
wall. Polyvinyl catheters (Bolab, Lake Havasu City, AZ)
were placed in the right and left brachiocephalic arteries,
and the right brachiocephalic vein. Stainless steel elec-
trodes were implanted biparietally on the dura for the re-
cording of electrocortical activity (ECoG) and over the
sternum for recording electrocardiogram (ECG). An in-
flatable silicone occluder cuff (OCHD16; In Vivo Metric,
Healdsburg, CA) was positioned around the proximal por-
tion of the umbilical cord and secured to the abdominal
skin. Once the fetus was returned to the uterus, a catheter
was placed in the amniotic fluid cavity and subsequently
in the maternal femoral vein. Antibiotics were adminis-
tered intra-operatively to the mother, (0.2 g trimethoprim
and 1.2 g sulfadoxine, Schering Canada Inc., Pointe-Claire,
Canada), fetus and amniotic cavity (1 million IU penicillin
G sodium, Pharmaceutical Partners of Canada, Richmond
Hill, Canada). Amniotic fluid lost during surgery was re-
placed with warm saline. The uterus and abdominal wall
incisions were sutured in layers and catheters exteriorized
through the maternal flank and secured to the back of the
ewe in a plastic pouch.
Animals were allowed a 3–4-day postoperative period
prior to experimentation, during which the antibiotic ad-
ministration was continued. Arterial blood was sampled
each day for evaluation of fetal condition and catheters
were flushed with heparinized saline to maintain patency.
Data and blood sample acquisition
A computerized data acquisition system was used to rec-
ord pressures in the fetal brachiocephalic artery and am-
niotic cavity at 256 Hz, and the ECG and ECoG signals
at 1000 Hz. All signals were monitored continuously
throughout the experiment using Chart 5 for Windows
(ADInstruments Pty Ltd, Bella Vista, Australia).
Fetal 3-mL blood samples were immediately spun at
4 °C (4 min, 4000 rpm; Beckman TJ-6, Fullerton, CA)
and the plasma decanted and stored at −80 °C for subse-
quent cytokine analysis. In addition, to characterize
baseline health status of the animals, fetal 1-mL blood
samples were analyzed for blood gas values, pH, glucose,
and lactate with an ABL-725 blood gas analyzer (Radi-
ometer, Copenhagen, Denmark) with temperature cor-
rected to 39 °C.
At the end point of each experiment as detailed below,
the ewe and fetus were killed with an overdose of barbitur-
ate (30 mg pentobarbital sodium, Fatal-Plus; Vortech
Pharmaceuticals, Dearborn, MI) and a post mortem
was carried out during which fetal gender and weight
were determined, and the location and function of
the umbilical cord occluder cuff were confirmed. The
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fetal brain was then perfusion-fixed with 500 mL of
cold saline followed by 500 mL of 4 % paraformalde-
hyde and processed for histochemical analysis as re-
ported [16, 18, 49].
Experimental procedures
As reported [17, 50], animals were studied through a 1-
to 2-h baseline period, an experimental period of repeti-
tive UCO with worsening acidemia, and were then
allowed to recover overnight. Five additional age-
matched additional animals were used as controls for
immunohistochemistry.
After the baseline period which began at ~8 a.m., re-
petitive UCO were performed with increasing frequency
until severe fetal acidemia was detected (arterial pH
<7.00), at which time the UCO were stopped. Complete
UCO was induced by inflation of the occluder cuff with
~5 mL saline solution, the exact volumes having been
determined by visual inspection and testing at the time
of surgery for each animal. During the first hour, a mild
UCO series was performed consisting of cord occlusion
lasting for 1 min and repeating every 5 min. During the
second hour, a moderate UCO series was performed
consisting of cord occlusion for 1-min duration and re-
peating every 3 min. During the third hour, a severe
UCO series was performed consisting of cord occlusion
for 1 min duration, repeated every 2 min, and this series
was continued until the targeted fetal arterial pH was
attained. Following the mild as well as the moderate
UCO series 10-min periods with no UCO were under-
taken, during which fetal arterial blood was sampled and
arterial blood pressure, ECOG, and ECG data were re-
corded in the absence of fetal heart rate decelerations.
After attaining the targeted fetal arterial pH of <7.00 and
stopping the repetitive UCO, animals were allowed to
recover for ~24 h.
Fetal arterial blood samples were obtained during the
baseline period (3 mL), at the end of the first UCO of
each UCO series (1 mL), and ~5 min after each UCO
series (3 mL). In addition, fetal arterial blood samples
were obtained between UCO at ~20 and 40 min of the
moderate and severe UCO series (1 mL), and at 1, 2,
and 24 h of recovery (3 mL). At ~4 p.m. on day 2, the
animals were killed as described above.
Measurements of inflammatory responses
Systemic IL-1β and IL-6 secretion
An ELISA was used to analyze in duplicate the concen-
trations of IL-1β and IL-6 in fetal arterial and maternal
venous plasma samples as reported [17]. IL-1β and IL-6
standards were purchased from the University of Mel-
bourne, Centre of Animal Biotechnology, Melbourne,
Australia. Mouse anti-ovine IL-1β (MAB 1001) and IL-6
(MAB 1004) antibodies and rabbit anti-ovine IL-1β (AB
1838) and IL-6 (AB 1889) polyclonal antibodies were
purchased from Chemicon International, Temecula, CA.
Separate 96-well plates were coated with mouse mono-
clonal ovine IL-1β or IL-6 antibody (1:200, in 0.1 M
NaCO3, pH to 9.6) and incubated overnight at 4 °C. The
following day, plates were washed three times with wash
solution (1× PBS with 0.05 % Tween, pH to 7.4) to re-
move excess monoclonal antibody. Plates were then
blocked with assay diluent (555213, BD OptEIA, BD
Biosciences) at room temperature for 1 h. Wells were
then rinsed three times with the wash solution followed
by aliquoting standards (40,000 pg/mL to 156 pg/mL
and blanks) and samples, and incubation on the shaker
at room temperature for 2 h. Subsequently, wells were
rinsed three times with washing solution and the appro-
priate rabbit anti-ovine polyclonal antibody (IL-1β or IL-
6, 1:500) was added to each well and incubated on the
shaker for 1 h. Following five more washes, HRP-donkey
anti-rabbit IgG (AP182p, Chemicon International,
1:10,000) was added to each well and incubated on the
shaker for 1 h. The wells were then washed seven times
with wash solution to remove all unbound secondary
antibody, followed by the addition and 30 min incuba-
tion with substrate solution (51-2606KC & 51-2607KC,
BD Biosciences) in the dark. Stop solution (1 N H2SO4)
was applied and each well was read using a spectropho-
tometer at 450 nm, with 575 nm wavelength correction.
Measures of neuroinflammation: immunohistochemistry
to assess microglia counts
These methods and findings have been reported [17].
The focus of this study was the putative relationship be-
tween the changes in microglia (MG) count in the white
matter we had reported and the fHRV as proxy for CAP
activity. Below we report the method as it was applied
for all brain regions. Brain regions that were selected
from each animal for analysis were taken from a coronal
section of blocked cerebral hemisphere tissue at the level
of the mammillary bodies and included the parasagittal
and convexity cerebral gray matter, periventricular white
matter, thalamus, CA1, dentate gyrus (DG), and the
combined CA2 and CA3 regions of the hippocampus.
Each of the parasagittal and convexity cerebral gray mat-
ter regions was further divided into subregions combin-
ing layers 1, 2, and 3 and layers 4, 5, and 6.
The presence of MG in brain tissue sections was
determined as previously reported [17, 18]. Briefly, to
reduce staining variability, all immunohistochemistry
was performed on the same day with the same batch of
antibody and solutions. Tissue sections were incubated
with an anti-IBA1 rabbit polyclonal antibody (1:500,
Wako Industries, Richmond, VA), a robust marker for
sheep MG, followed by incubation with biotinylated
goat anti-rabbit IgG, and subsequently with avidin-
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bioton-peroxidase complex (both Vectastain Elite; Vec-
tor Laboratories, Burlingame, CA). Positively bound
antibody/peroxidase complex was detected using Car-
dassian Diaminobenzidine (DAB) Chromogen (Biocare
Medical, Concord, CA).
Images were captured with a transmitted light micro-
scope (Leica DMRB, Leica-Microsystems, Wetzler,
Germany) at ×40 magnification. Six high-power field
(HPF) photomicrographs (HPF area = 7 cm2) per brain
region/subregion per animal were randomly collected
as a 24-bit RGB color modeled image. The same illu-
mination setting was applied to all images for all of the
brain regions, and the microscope and lamp alignment
were set up to provide even lighting with no back-
ground signal.
Positive MG cell immunostaining was quantified with
an image analysis program (Image Pro Plus 6.0, Media
Cybernetics, Silver Spring, MD). The image analysis sys-
tem was first calibrated for the magnification settings that
were used, then, using the Image Pro Plus’ RGB selection
tool, color samplings of positive DAB stained areas were
obtained from multiple brain regions as RGB histogram
thresholds and tested for specificity against the negative
control. Appropriate ranges of color were selected show-
ing positive contiguous cytoplasmic staining as a criterion
for MG cell count scoring, which were then applied uni-
formly to calibrated images for all brain regions. Scoring
was then performed automatically by the software in a
blinded fashion to experimental groups.
Measures of neuroinflammation: immunohistochemistry
to quantify HMGB1 translocation in Iba1+ microglia
expressing α7 nAChR
Similar to MG analyses, whole brain coronal sections
through the level of the mammillary body were selected
for analysis. Paraffin sections (5 μM thick) were dewaxed
and rehydrated through graded alcohols. All tissue sec-
tions for analysis were processed simultaneously, using
pooled reagents and antibodies for consistency. Heat-
induced epitope retrieval was performed in a vegetable
steamer using sodium citrate buffer, pH 6.0, for 25 min,
followed by slow cooling to room temperature. Sniper
background blocker (Biocare Medical, Concord CA) was
applied to reduce non-specific background. Subse-
quently, the antibodies described in Additional file 1:
Table S1 were applied as follows. Phosphate-buffered sa-
line (PBS pH 7.4) rinses were performed between each
step and staining was performed at room temperature. A
cocktail of Iba1 and α7 nAChR primary antibodies was
applied and incubated for 1 h. A cocktail of Alexa 568
anti-Rabbit and Alexa 647 anti-Mouse secondary anti-
bodies was applied and incubated for 30 min. Using a
method exhaustively tested in our laboratory to utilize
two antibodies from the same species, the ability of the
anti-rabbit secondary antibody to bind further was then
blocked with 4 μg/mL of pre-immune non-specific
rabbit IgG for 30 min, before applying the conjugated
Alexa 488 HMGB1 antibody and incubating for 1 h. Tis-
sues were rinsed in PBS, counterstained with DAPI, and
mounted in Prolong Gold anti-fade mounting media
(Molecular Probes, Invitrogen, Carlsbad, CA) to preserve
fluorescent signal throughout the image capture.
Images were captured on a Zeiss AxioImager Z1
microscope, equipped with an Apotome grid-a struc-
tured illumination device, which isolates optical slices
much like a confocal microscope (Carl Zeiss Canada
Ltd, Toronto, ON). For each animal, eight random fields
of view in each brain region were collected for analysis.
All images within each brain region were captured at the
same instrument settings to ensure consistent illumin-
ation and detection parameters among samples. To
avoid crosstalk between channels that might create non-
specific intensity signals, bandpass dichroic filters for
each dye were carefully selected based on the spectral
profiles of the fluorescent tags and tested against con-
trols that are positive for that desired dye wavelength,
but negative for all other dyes used. Images were cap-
tured sequentially using one filter set at a time for each
channel. The image analysis was done in Image Pro Plus
7.0 (Media Cybernetics, Bethesda, MD, USA) as pub-
lished [51]. All image analyses were performed on 8-bit
tiff images calibrated for scale measured per pixel on a
scale of 0 (black)–255 (white) within the area of interest
(cytosol or nuclei). Area was calibrated to square mi-
crons. Intensity/area yielded a mean intensity/square mi-
cron. In all analyses, samples of non-tissue background
areas were measured for intensity, and positive signal
histogram settings were chosen to selectively measure
signal above this background. Thus, mean intensity/
square micron area of the sampling region is reported
for HMGB1 and α7 nAChR.
We co-labeled with the HMGB1, α7 nAChR, Iba1, and
DAPI, yielding four separate channels that we used as fol-
lows (Fig. 4 demonstrates this four-channel approach in-
cluding negative controls). The original four-channel
images were exported as separate greyscale tiffs for each
fluorescent channel, representing HMGB1 (Alexa488), α7
nAChR (Alexa647), Iba1 (Alexa568), and DAPI/nucleus.
Using the DAPI and Iba1 channel images, we used binary
masking techniques to isolate regions of interest (ROIs)
specific to only the nuclear and cytosolic signal regions of
MG whole cells in two distinct cell populations (further
described below). Image Pro allows us to save these out-
lines as geographic regions and reapply them as counting
regions to the other channel images. These outlines were
saved and reapplied separately to the matching, isolated
HMGB1, and then α7 nAChR greyscale images, and inten-
sity and area data from within those nuclear and then
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cytosolic outlines was collected, yielding separate data
points for nuclear HMGB1, cytosolic HMGB1, nuclear α7
nAChR, and cytosolic α7 nAChR.
We discriminated and report separately active and qui-
escent microglia (aMG, qMG) based on the morpho-
logical features of the Iba1+ cells and their location in
relation to the neurons: as aMG were considered Iba1+
cells exhibiting large (~2× fold) soma and processes
engulfing neighboring neurons, while qMG did not ex-
hibit either of these features (Fig. 4). We recognize that
such distinction, albeit based on general consensus re-
garding distinct morphological features of active (hyper-
trophy and increased processes) versus quiescent
microglia, is also somewhat subjective, when it comes to
the notion of co-localization to or engulfing of neurons.
We return to this in the Discussion section.
For analyses of HMGB1 and α7 nAChR intensity per
area between the brain regions within each group, we
had to take into account that their absolute values could
not be compared due to region-specific optimized acqui-
sition as described above. For HMGB1, we worked
around this limitation by deriving relative measures of
HMGB1 intensity per area as cytosol/nucleus ratio for
each brain region, as HMGB1 translocation indices (the
higher the ratio, the more translocation occurs), thus
making them comparable.
Do umbilical cord occlusions result in vagal activation on
the level of the brainstem’s vagal motor nucleus:
immunohistochemistry for c-Fos
We aimed to detect UCO-triggered vagus nerve-mediated
neuronal activation in the dorsal motor nucleus of the
brainstem. We referred to the Michigan State University
Brain Atlas to locate the nucleus in our brain stem slides
(cf. Additional file 3). We used an immediate early gene
detection approach deployed widely in other species, such
as rodents, by performing c-Fos immunostaining with a c-
Fos transcription factor monoclonal anti-human antibody
(LifeSpan Biosciences, Seattle, WA) generated from a pep-
tide corresponding to amino acids 128–152 of human c-
Fos. This region has 100 % homology to the sheep c-Fos
protein. This is the only commercially available antibody
expected to generate signal in sheep tissue. We validated
this antibody in our available ovine brain tissue homoge-
nates using Western blot (described below, Additional file
2: Figure S1A and B).
Staining was performed using the anti-mouse Imm-
Press polymerized peroxidase reporter enzyme kit (Vec-
tor Laboratories, Burlingame, CA), followed by detection
using DAB Chromogen (Biocare Medical, Concord, CA).
The functional chemistry of kit reagents was verified
using antibodies and tissues known to work in our la-
boratories, specifically mouse anti-human myelin basic
protein (LifeSpan Biosciences, Seattle, WA) in guinea
pig brain tissue prepared using similar fixation and pro-
cessing conditions. As positive and negative tissue con-
trols, brain tissues from a different fetal sheep study
being performed in our laboratory were run concur-
rently with UCO and control animals. In this study,
afferent (positive control) and efferent (negative control)
bilateral cervical vagus nerve stimulation (VNS) was
accompanied by intravenous injection of endotoxin to
trigger inflammatory response in fetal sheep near term
[45, 46, 52, 53]. Twelve dilutions of c-Fos antibody were
tested with various antigen retrieval methods. Dilutions
ranged from 1 μg/ml, which yielded no stain, to 20 μg/
mL which yielded very high background in all cells re-
gardless of antigen retrieval method. Several antigen re-
trieval methods were attempted and compared. Both
10 mM Citrate pH 6.0 heat retrieval and 10 mM Tris-
HCL/1 mM EDTA/0.05 % Tween pH 9.0 nuclear antigen
retrieval methods were attempted at 25 and 40 min time
points, using both steam and pressure cooker methods.
At 37 °C, 0.1 % Trypsin incubation was also tested at 15,
20, and 25 min. While trypsin at 20 min appeared to
generate some nuclear signal in a few neurons in the af-
ferent VNS animals at dilutions of 5–20 μg/ml, the sig-
nal was diffused with high levels of background stain
and could not be found in the nuclei of neuronal cells in
the motor nucleus of the vagus (Additional file 2: Figure
S1C). Furthermore, this trypsin treatment damaged the
tissues and caused them to become ragged and fall off
the slides in places.
Western blot for α7 nAChR and c-Fos
The presence of the α7 nAChR and c-Fos proteins in
sheep brain tissue was analyzed by Western blot. Fetal
sheep brainstem, cerebellum and cortex were homoge-
nized in lysis buffer (1× RIPA buffer, Cell Signalling
Technology, Cat # 9806) with fresh addition of PMSF
(1 mM, Sigma P7626) just before use and quantified by
BioRad Protein Assay method (BioRad Cat # 500-0006).
At 120 V, 30 μg of protein was subjected to electrophor-
esis for 90 min in 10 % denaturing polyacrylamide gels.
Proteins were then electrotransferred onto 0.45 μM
nitrocellulose membrane (BioRad #162-0115) at 100 V
for 2 h at 4 °C in transfer buffer (190 mM glycine,
25 mM Tris-base, and 20 % methanol, pH 8.3). After
blocking for 1 h in TBST (0.5 % Tween 20, 50 mM Tris-
HCl, 150 mM NaCl) with 5 % skimmed milk, blots were
incubated with primary antibody (either a rat anti-
chicken α7 nAChR monoclonal antibody (Sigma N8158)
at 1:5000 dilution or a mouse anti-human c-Fos poly-
clonal antibody (LSBio, LS-C77393) at 1:500 dilution) in
0.5 % TBST with 5 % skimmed milk overnight at a cold
room, followed by three washes (10 min each) with
0.1 % TBST. The blots were then incubated with sec-
ondary antibody (for α7 nAChR, a goat anti-rat IgG
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HRP (Life Technologies, #A18865) at 1:10000 dilution;
for c-Fos, a rabbit anti-mouse IgG HRP antibody
(Abcam, ab6728) at 1:5000 dilution) in 0.5 % TBST with
5 % skimmed milk for 1 h with agitation, followed by
three washes (10 min each) with 0.1 % TBST. The blots
were further incubated with ECL detection reagents (GE
Healthcare #2209) for 3 min, and then imaged using
ImageQuant LAS 4000 Mini system (GE Healthcare).
Beta-actin was used as loading control; after striping and
blocking, the blots were probed with a mouse anti-
mouse β-actin monoclonal primary antibody (1: 500 di-
lution, Abcam, ab8226) and followed by a rabbit anti-
mouse IgG HRP secondary antibody (1:5000 dilution,
Abcam, ab6728) both in 0.5 % TBST with 3 % BSA, ECL
detection, and imaging as described above. Precision
Plus Protein Standards (BioRad 161-0374) was used to
estimate molecular size of the target protein.
Fetal heart rate variability analysis to gauge activity of
the cholinergic anti-inflammatory pathway
The fHRV methodology was described elsewhere [2, 54].
Briefly, R peaks were triggered by steepest ascent criterion
to derive fHRV, and RMSSD was calculated from 5 min of
fHRV using Matlab 6.1, R13 (The MathWorks, Natick,
Massachusetts, USA). We selected 10-min intervals of
artifact-free fetal ECG for each time point. ECG-derived
fHRV segments were analyzed time-matched to the cyto-
kine samples taken at baseline and during the UCO series.
In addition, fHRV measures were correlated to the brain’s
white matter microglia cell counts and brain region- and
cell compartment-specific α7nAChR and HMGB1 signals
in the Iba1+ microglia (see above). CAP activation was
measured as increases in fHRV measure RMSSD that
reflects vagal modulation of fHRV [2].
Statistical analyses
Blood gas, pH, IL-1β, and fHRV-derived measurements
in response to repetitive cord occlusions were compared
to the corresponding baseline values by one-way re-
peated measures ANOVA with Holm-Sidak method of
correction for multiple comparisons. A generalized esti-
mating equations (GEE) model was used to assess the
effects of UCO on HMGB1 translocation while account-
ing for repeated measurements in space across the brain
regions with AR [1] correlation matrix. We used a linear
scale response model with animal group, MG type
(qMG, aMG), and brain regions as predicting factors to
assess their interactions using maximum likelihood esti-
mate and Type III analysis with Wald Chi-square statis-
tics. A similar analysis was made to assess the behavior
of α7 nAChR intensity per area across the groups and
MG type with HMGB1 translocation index as covariate,
but using an independent correlation matrix (α7 nAChR
intensity per area between brain regions within each
group could not be compared, since absolute values had
to be used; hence no repeated measurements across the
brain regions were assessed for α7 nAChR intensity per
area values). Correlation analysis was performed using
Spearman correlation coefficient (IBM SPSS Statistics
Version 21, IBM Corporation, Armonk, NY). Signifi-
cance was assumed for p < 0.05. Results are provided as
means ± SD or as median [55] percentile, as appropriate.
Not all measurements were obtained for each animal
studied (see Figure legends).
Additional files
Additional file 1: Table S1. Immunohistochemistry reagents used to
quantify HMGB1 translocation in Iba1+ microglia expressing α7 nAChR.
Table S2. Effect of UCO, microglia status and brain regions on the
HMGB1 translocation index. Parameter Estimates. Table S3. Effect of
UCO, microglia status and HMGB1 translocation on α7 nAChR signal.
(DOCX 82 kb)
Additional file 2: Figure S1. C-Fos in fetal sheep brain. A. Western blot
establishing the specificity of this antibody in near-term fetal sheep
brainstem, cerebellum and cortex. B. Western blot: raw data of the image
shown in Fig. S1A. C. c-Fos immunohistochemistry (IHC) in near-term fetal
sheep and guinea pig brainstems. Top left: positive control staining. The
cervical vagus nerve trunks were stimulated bilaterally (the stimulation
was applied proximal to the bilateral cervical vagatomy to ensure strictly
afferent signaling). Note diffuse c-Fos signal with high levels of
background stain. Top right: negative control staining. Similar procedure
was performed as in afferent stimulation, except the stimulation was
performed distal of the vagatomy site ensuring strictly efferent signaling.
Bottom left: example of a UCO group fetal sheep staining. Bottom right:
Here we demonstrate the IHC approach regarding secondary antibody
and visualization techniques; as primary antibody we used MBP (details in
Methods). (ZIP 85110 kb)
Additional file 3: Motor Nucleus of Vagus—Location. Methods
supplementary material: Neuroanatomical approach to locating vagal
motor nucleus in fetal sheep brain (PDF 1716 kb)
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